Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible cases
Vadwai, V.; Boehme, C.; Nabeta, P.; Shetty, A.; Rodrigues, C.
Indian Journal of Medical Research 135(4): 560-561
2012
ISSN/ISBN: 0019-5340 PMID: 22664508 Document Number: 657276
Document emailed within 1 workday
Related Documents
Farer, L.S.; Long, M.W.; Snider, D.E. 1981: Isoniazid-rifampin regimens for tuberculosis Annals of Internal Medicine 95(4): 518-519Gurumurthy, P.; Ramachandran, G.; Hemanth Kumar, A.K.; Rajasekaran, S.; Padmapriyadarsini, C.; Swaminathan, S.; Venkatesan, P.; Sekar, L.; Kumar, S.; Krishnarajasekhar, O.R.; Paramesh, P. 2004: Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 38(2): 280-283
O'Brien, R.J.; Long, M.W.; Cross, F.S.; Lyle, M.A.; Snider, D.E. 1983: Hepatotoxicity from isoniazid and rifampin among children treated for tuberculosis Pediatrics 72(4): 491-499
Long, C.F.; Zhang, Y.; Lou, Y.C. 1997: Effects of rifampin and isoniazid on the pharmacokinetics of diazepam in rabbits Yao Xue Xue Bao 32(7): 481-484
Van Scoy, R.E.; Wilkowske, C.J. 1983: Antituberculous agents. Isoniazid, rifampin, streptomycin, ethambutol, and pyrazinamide Mayo Clinic Proceedings 58(4): 233-240
Ashwini, M.; Ashwini, N.; Arunkumar, N.; Gunasheela, D. 2020: A Study on Diagnostic Evaluation of two Different Rapid DNA Polymerase Chain Reaction Techniques Namely Gene Xpert Mycobacterium Tuberculosis/Rifampin (MTB/RIF) and Mycoreal Polymerase Chain Reaction in the Diagnosis of Endometrial Tuberculosis Considering Culture as Gold Standard Journal of Human Reproductive Sciences 13(4): 290-295
Gardella, N.; Picasso, R.; Predari, S.C.; Lasala, M.; Foccoli, M.; Benchetrit, G.; Famiglietti, A.; Catalano, M.; Mollerach, M.; Gutkind, G. 2005: Methicillin-resistant Staphylococcus aureus strains in Buenos Aires teaching hospitals: replacement of the multidrug resistant South American clone by another susceptible to rifampin, minocycline and trimethoprim-sulfamethoxazole Revista Argentina de Microbiologia 37(3): 156-160
Tsukamura, M.; Yamori, S. 1990: In-vitro susceptibility of Mycobacterium avium complex to isoniazid and ethionamide Kekkaku: 65(3): 243-247
Jia, P.-p.; Zhao, L.-l.; Li, X.-y.; Zhang, Q.; Liu, Z.-l.; Wang, X.; Yu, L.-y.; Zhao, L.-x.; Cen, S. 2011: Establishment and drug susceptibility test of isoniazid resistant Mycobacterium smegmatis Yao Xue Xue Bao 46(4): 377-382
van Halsema, C.L.; Fielding, K.L.; Chihota, V.N.; Russell, E.C.; Lewis, J.J.C.; Churchyard, G.J.; Grant, A.D. 2010: Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence setting Aids 24(7): 1051-1055
Mitarai, S.; Kobayashi, I.; Abe, C.; Wada, M.; Suzuki, K.; Takashima, T.; Kawabe, Y.; Machida, K.; Tano, M.; Takigawa, S.; Kamada, A.; Shigetoh, E.; Fujii, S.; Mori, K.; Suyama, H.; Yano, S.; Kawashiro, T.; Ogata, H. 2007: Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid Kekkaku: 82(5): 449-454
Gordin, F.; Chaisson, R.E.; Matts, J.P.; Miller, C.; de Lourdes Garcia, M.; Hafner, R.; Valdespino, J.L.; Coberly, J.; Schechter, M.; Klukowicz, A.J.; Barry, M.A.; O'Brien, R.J. 2000: Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group JAMA 283(11): 1445-1450
Wibaux, Cécile.; Andrei, I.; Paccou, J.; Philippe, P.; Biver, E.; Duquesnoy, B.; Flipo, Ré.Marc. 2010: Pregnancy during TNFalpha antagonist therapy: beware the rifampin-oral contraceptive interaction. Report of two cases Joint Bone Spine 77(3): 268-270
Nabih, I.; el Ansary, A. 1993: Kinetic potentials of certain scavenger enzymes in fresh water snails susceptible and non-susceptible to Schistosoma infection Cellular and Molecular Biology 39(4): 449-454
Nabih, I.; el-Ansary, A. 1992: Succinate-DCPIP and NADH-fumarate oxidoreductases in fresh water snails susceptible and non susceptible to schistosoma infection Cellular and Molecular Biology 38(2): 131-134
Martin, W.J.; Esber, E.; Cotton, W.G.; Rice, J.M. 1975: Normal tissue alloantigens and genetic control of susceptibility to tumors: microcytotoxicity studies on resistant C3Hf and susceptible (A X C3Hf) F1 mice inoculated with transplacentally induced C3Hf lung tumor Journal of Immunology 115(1): 289-295
Königshausen, T.; Altrogge, D.; Hein, D.; Grabensee, B.; Pütter, J. 1978: Isoniazid elimination by means of hemodialysis and hemoperfusion in acute isoniazid poisoning Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 1241-1244
Belianin, I.I. 2004: Decreased resistance of multiresistant mycobacteria to isoniazid during the treatment of experimental tuberculosis with ozone and isoniazid Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2004(3): 95-98
Amlabu, V.; Mulligan, C.; Jele, N.; Evans, A.; Gray, D.; Zar, H.J.; McIlleron, H.; Smith, P. 2014: Isoniazid/acetylisoniazid urine concentrations: markers of adherence to isoniazid preventive therapy in children International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 18(5): 528-530
Mthiyane, T.; Millard, J.; Adamson, J.; Balakrishna, Y.; Connolly, C.; Owen, A.; Rustomjee, R.; Dheda, K.; McIlleron, H.; Pym, A.S. 2020: N-Acetyltransferase 2 Genotypes among Zulu-Speaking South Africans and Isoniazid and N-Acetyl-Isoniazid Pharmacokinetics during Antituberculosis Treatment Antimicrobial Agents and ChemoTherapy 64(4)